Splicing isoform of SYT-SSX fusion protein accelerates transcriptional activity and cell proliferation

Cancer Letters

Volumn 199, Issue 1, 2003, Pages 35-43

  Morimoto, Yuki ^a   Ouchida, Mamoru ^a   Ozaki, Toshifumi ^a   Kawai, Akira ^b   Ito, Tatsuo ^a   Yoshida, Aki ^a   Inoue, Hajime ^a   Shimizu, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Alternative splicing; Cell growth; SSX; Synovial sarcoma; SYT; Transcriptional activity

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; ISOPROTEIN; LUCIFERASE; PROTEIN SYT SSX; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYMATIC ASSAY; GENE INSERTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SPLICING; SYNOVIAL SARCOMA;

INSERTION SEQUENCES;

EID: 0042881136     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00314-8     Document Type: Article

References (27)

1. Clark J., Rocques P.J., Crew A.J., Gill S., Shipley J., Chan A.M., Gusterson B.A., Cooper C.S. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet. 7:1994;502-508.
2. Fligman I., Lonardo F., Jhanwar S.C., Gerald W.L., Woodruff J., Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am. J. Pathol. 147:1995;1592-1599.
3. Skytting B., Nilsson G., Brodin B., Xie Y., Lundeberg J., Uhlen M., Larsson O. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J. Natl Cancer Inst. 91:1999;974-975.
4. De Bruijn D.R., Baats E., Zechner U., De Leeuw B., Balemans M., Olde Weghuis D., Hirning-Folz U., Geurts Van Kessel A.G. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene. 13:1996;643-648.
5. Brett D., Whitehouse S., Antonson P., Shipley J., Cooper C., Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies. Hum. Mol. Genet. 6:1997;1559-1564.
6. Thaete C., Brett D., Monaghan P., Whitehouse S., Rennie G., Rayner E., Cooper C.S., Goodwin G. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum. Mol. Genet. 8:1999;585-591.
7. Nagai M., Tanaka S., Tsuda M., Endo S., Kato H., Sonobe H., Minami A., Hiraga H., Nishihara H., Sawa H., Nagashima K. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc. Natl Acad. Sci. USA. 98:2001;3843-3848.
8. Eid J.E., Kung A.L., Scully R., Livingston D.M. p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell. 102:2000;839-848.
9. De Bruijn D.R., Dos Santos N.R., Thijssen J., Balemans M., Debernardi S., Linder B., Young B.D., Geurts Van Kessel A. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene. 20:2001;3281-3289.
10. Crew A.J., Clark J., Fisher C., Grimed R., Chand A., Shipley J., Mitchell P. Fusion in two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J. 14:1995;2333-2340.
11. Gure A.O., Tureci O., Sahin U., Tsang S., Scanlan M.J., Jager E., Knuth A., Pfreundshuh M., Old L.J., Chen Y.T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer. 72:1997;965-997.
12. Brett D., Whitehouse S., Per A., Shipley J., Cooper G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies. Hum. Mol. Genet. 6:1997;1559-1564.
13. Lim F.L., Soulez M., Koczan D., Thiesen H.J., Knight J.C. KRAB-related domain and a novel transcription repressor domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene. 17:1998;2013-2018.
14. dos Santos N.R., Diederik R.H., de Bruijn, Geurts van Kessel A. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 30:2001;1-14.
15. de Leeuw B., Balemans M., Olde Weghuis D., Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum. Mol. Genet. 4:1995;1097-1099.
16. Tamborini E., Agus V., Mezzelani A., Riva C., Sozzi G., Azzarelli A., Pierotti M.A., Pilotti S. Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma. Br. J. Cancer. 84:2001;1087-1094.
17. Brodin B., Haslam K., Yang K., Bartolazzi A., Xie Y., Starborg M., Lundeberg J., Larsson O. Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression. Gene. 268:2001;173-182.
18. Naito N., Kawai A., Ouchida M., Dan'ura T., Morimoto Y., Ozaki T., Shimizu K., Inoue H. A reverse transcriptase-polymerase chain reaction assay in the diagnosis of soft tissue sarcomas. Cancer. 89:2000;1992-1998.
19. Kukita A., Kukita T., Maeda H., Ouchida M., Yatsuki H., Kohashi O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional regulator, is involved in osteoclastogenesis. Blood. 94:1999;1987-1997.
20. Oka T., Ouchida M., Koyama M., Ogama Y., Takada S., Nakatani Y., Tanaka T., Yoshino T., Hayashi K., Ohara N., Kondo E., Takahashi K., Tsuchiyama J., Tanimoto M., Shimizu K., Akagi T. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res. 62:2002;6390-6394.
21. Fisher C. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum. Pathol. 17:1986;996-1008.
22. Smith M.E., Fisher C., Wilkinson L.S., Edwards J.C. Synovial sarcoma lack synovial differentiation. Histopathology. 26:1995;279-281.
23. Shibuya Y., Okabayashi T., Oda K., Tanaka N. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma. Jpn J. Clin. Oncol. 28:1998;609-614.
24. Kuryu M., Ozaki T., Nishida K., Shibahara M., Kawai A., Inoue H. Expression of CD44 variants in osteosarcoma. J. Cancer Res. Clin. Oncol. 125:1999;646-652.
25. Kim H.S., Park Y.B., Oh J.H., Jeong J., Kim C.J., Lee S.H. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma. Clin. Orthop. 396:2002;184-190.
26. Miyake H., Eto H., Arakawa S., Kamidono S., Hara I. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer. J. Urol. 167:2002;1282-1287.
27. Ghert M.A., Jung S.T., Qi W., Harrelson J.M., Erickson H.P., Block J.A., Scully S.P. The clinical significance of tenascin-C splice variant expression in chondrosarcoma. Oncology. 61:2001;306-314.